The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

(RTTNews) - Quest Diagnostics (DGX) reaffirmed its guidance for full year 2025. The company continues to project: adjusted EPS in a range of $9.55 to $9.80, and net revenues in a range of $10.70 ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, March ...

Regulatory frameworks and reimbursement models must evolve to support AI diagnostics. Addressing these barriers is crucial to democratizing medical expertise. AI streamlines healthcare workflows ...